UnitedHealth Net Tangible Assets from 2010 to 2026
| UNH Stock | USD 293.19 8.82 3.10% |
Net Tangible Assets | First Reported 2009-06-30 | Previous Quarter -30.2 B | Current Value 89.6 B | Quarterly Volatility 28 B |
Check UnitedHealth Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among UnitedHealth Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.6 B, Total Revenue of 469.9 B or Gross Profit of 87.1 B, as well as many indicators such as Price To Sales Ratio of 1.16, Dividend Yield of 0.0277 or PTB Ratio of 3.21. UnitedHealth financial statements analysis is a perfect complement when working with UnitedHealth Group Valuation or Volatility modules.
UnitedHealth | Net Tangible Assets | Build AI portfolio with UnitedHealth Stock |
The Net Tangible Assets trend for UnitedHealth Group Incorporated offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether UnitedHealth Group is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest UnitedHealth Group's Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of UnitedHealth Group Incorporated over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. UnitedHealth Group's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in UnitedHealth Group's overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
UnitedHealth Net Tangible Assets Regression Statistics
| Arithmetic Mean | (9,057,815,882) | |
| Geometric Mean | 10,203,331,527 | |
| Coefficient Of Variation | (264.04) | |
| Mean Deviation | 14,570,811,211 | |
| Median | (14,631,000,000) | |
| Standard Deviation | 23,916,392,352 | |
| Sample Variance | 571993823.1T | |
| Range | 103.9B | |
| R-Value | (0.26) | |
| Mean Square Error | 569558063.7T | |
| R-Squared | 0.07 | |
| Significance | 0.32 | |
| Slope | (1,221,268,039) | |
| Total Sum of Squares | 9151901170.3T |
UnitedHealth Net Tangible Assets History
About UnitedHealth Group Financial Statements
Investors use fundamental indicators, such as UnitedHealth Group's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although UnitedHealth Group's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | -28.8 B | -27.4 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of UnitedHealth Group Correlation against competitors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is there potential for Health Care Providers & Services market expansion? Will UnitedHealth introduce new products? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (1.00) | Dividend Share 8.73 | Earnings Share 19.2 | Revenue Per Share | Quarterly Revenue Growth 0.123 |
Understanding UnitedHealth Group requires distinguishing between market price and book value, where the latter reflects UnitedHealth's accounting equity. The concept of intrinsic value - what UnitedHealth Group's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push UnitedHealth Group's price substantially above or below its fundamental value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, UnitedHealth Group's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.